Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

NCT02007512 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Enzalutamide
DRUG: exemestane
DRUG: Placebo (for enzalutamide)
DRUG: exemestane

Sponsor

Pfizer

Collaborators

[object Object]
[object Object]